Annual Cash & Cash Equivalents:
$152.60M-$125.33M(-45.09%)Summary
- As of today, INBX annual cash & cash equivalents is $152.60 million, with the most recent change of -$125.33 million (-45.09%) on December 31, 2024.
- During the last 3 years, INBX annual cash & cash equivalents has risen by +$21.30 million (+16.22%).
- INBX annual cash & cash equivalents is now -45.09% below its all-time high of $277.92 million, reached on December 31, 2023.
Performance
INBX Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$153.09M-$33.48M(-17.94%)Summary
- As of today, INBX quarterly cash & cash equivalents is $153.09 million, with the most recent change of -$33.48 million (-17.94%) on September 30, 2025.
- Over the past year, INBX quarterly cash & cash equivalents has dropped by -$43.24 million (-22.03%).
- INBX quarterly cash & cash equivalents is now -54.62% below its all-time high of $337.33 million, reached on September 30, 2023.
Performance
INBX Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
INBX Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -45.1% | -22.0% |
| 3Y3 Years | +16.2% | +4.8% |
| 5Y5 Years | +1222.3% | +19.9% |
INBX Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -45.1% | +16.2% | -54.6% | +4.8% |
| 5Y | 5-Year | -45.1% | +1222.3% | -54.6% | +41.8% |
| All-Time | All-Time | -45.1% | +7156.1% | -54.6% | +2618.2% |
INBX Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $153.09M(-17.9%) |
| Jun 2025 | - | $186.57M(-13.8%) |
| Mar 2025 | - | $216.52M(+41.9%) |
| Dec 2024 | $152.60M(-45.1%) | $152.60M(-22.3%) |
| Sep 2024 | - | $196.33M(-13.5%) |
| Jun 2024 | - | $226.86M(-10.1%) |
| Mar 2024 | - | $252.48M(-9.2%) |
| Dec 2023 | $277.92M(+1.5%) | $277.92M(-17.6%) |
| Sep 2023 | - | $337.33M(+75.2%) |
| Jun 2023 | - | $192.49M(-17.8%) |
| Mar 2023 | - | $234.25M(-14.5%) |
| Dec 2022 | $273.87M | $273.87M(+87.5%) |
| Sep 2022 | - | $146.07M(-17.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $176.38M(+22.9%) |
| Mar 2022 | - | $143.47M(+9.3%) |
| Dec 2021 | $131.30M(+2.0%) | $131.30M(+16.5%) |
| Sep 2021 | - | $112.70M(-10.4%) |
| Jun 2021 | - | $125.73M(+16.4%) |
| Mar 2021 | - | $107.99M(-16.1%) |
| Dec 2020 | $128.66M(+1014.9%) | $128.66M(+0.8%) |
| Sep 2020 | - | $127.67M(+2166.9%) |
| Jun 2020 | - | $5.63M(-51.2%) |
| Dec 2019 | $11.54M(+448.7%) | $11.54M(-58.2%) |
| Jun 2019 | - | $27.63M(+342.4%) |
| Mar 2019 | - | $6.24M |
| Dec 2018 | $2.10M(-84.4%) | - |
| Dec 2017 | $13.47M | - |
FAQ
- What is Inhibrx Biosciences, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. annual cash & cash equivalents year-on-year change?
- What is Inhibrx Biosciences, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
What is Inhibrx Biosciences, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of INBX is $152.60M
What is the all-time high annual cash & cash equivalents for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high annual cash & cash equivalents is $277.92M
What is Inhibrx Biosciences, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, INBX annual cash & cash equivalents has changed by -$125.33M (-45.09%)
What is Inhibrx Biosciences, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of INBX is $153.09M
What is the all-time high quarterly cash & cash equivalents for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high quarterly cash & cash equivalents is $337.33M
What is Inhibrx Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, INBX quarterly cash & cash equivalents has changed by -$43.24M (-22.03%)